Sort by
Refine Your Search
-
Listed
-
Employer
- KINGS COLLEGE LONDON
- University of Oxford
- King's College London
- Durham University
- ;
- University of Cambridge
- University of London
- University of Birmingham
- University of Oxford;
- DURHAM UNIVERSITY
- John Innes Centre
- King's College London;
- Medical Research Council
- Nature Careers
- The University of Edinburgh;
- UNIVERSITY OF VIENNA
- University of Cambridge;
- University of Glasgow
- University of Liverpool
- University of Newcastle
- University of Nottingham
- University of Nottingham;
- 12 more »
- « less
-
Field
-
The laboratory of Prof. Simon Davis and Dr. Mafalda Santos at the MRC Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, is seeking a talented and motivated Postdoctoral
-
of murine models of high-grade lymphoma with the aim of providing pre-clinical evidence to support the development of metabolic inhibitors as novel treatments for lymphoma, alone or in combination with
-
of research projects on human immunity against bacterial and viral infections using human challenge models. You will support the research of Post-Doctoral Scientists, whilst obtaining training in working
-
following: Quantum chemistry (preferably of excited states) Multiscale simulations/environmental modelling Excited state dynamics Data Science/Machine learning in chemistry/Cheminformatics Molecular dynamics
-
renewable award. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of approaches including targeted genetic murine models, primary cell
-
About us The Green Laboratory investigates tissue morphogenesis and the action of morphogens. We use animal models to investigate the physical morphogenesis of tissues. It is part of the vibrant and
-
morphogenesis and the action of morphogens. We use animal models to investigate the physical morphogenesis of tissues. It is part of the vibrant and supportive environment of the Centre for Craniofacial
-
, Surveillance & Exploration). This innovative initiative, established in 2024, is a collaboration between the University of Oxford and GlaxoSmithKline (GSK) aimed at identifying molecular vulnerabilities in
-
, alongside strong skills in protein analysis, molecular biology, and imaging techniques. Additional expertise in studying autophagy and using preclinical mouse models of cardiovascular disease are highly
-
develop experience in in vivo modelling, molecular profiling, and drug testing, with access to state-of-the-art facilities and expert support. You will also benefit from tailored training and mentoring, and